Top PSC (Primary Sclerosing Cholangitis) Management in Houston, The Woodlands & Humble | DLDC Liver Experts

PSC (Primary Sclerosing Cholangitis) Management in Houston, The Woodlands & Humble

Advanced Liver Care for Rare Bile Duct Disorders
DLDC specializes in managing Primary Sclerosing Cholangitis (PSC), a rare and progressive bile duct disease. Our hepatology experts use advanced diagnostics, medication therapy, and ongoing monitoring to preserve liver function, manage symptoms, and improve quality of life.
PSC (Primary Sclerosing Cholangitis) Management in Houston, The Woodlands & Humble Advanced Liver Care for Rare Bile Duct Disorders DLDC specializes in managing Primary Sclerosing Cholangitis (PSC), a rare and progressive bile duct disease. Our hepatology experts use advanced diagnostics, medication therapy, and ongoing monitoring to preserve liver function, manage symptoms, and improve quality of life.
Primary Sclerosing Cholangitis (PSC) Management

Primary Sclerosing Cholangitis (PSC) Management in North Houston, Humble & The Woodlands

Primary Sclerosing Cholangitis (PSC) is a rare, chronic liver disease that causes inflammation and scarring of the bile ducts, leading to impaired bile flow, liver damage, and eventual cirrhosis. PSC is often associated with inflammatory bowel disease (IBD), particularly ulcerative colitis.

At DLDC, our expert hepatologists offer comprehensive care for PSC using advanced imaging (MRCP), blood tests, liver biopsy, and FibroScan® to monitor disease progression. While there is no cure, treatment focuses on managing symptoms, preventing complications, and evaluating the need for liver transplant in advanced stages.

DLDC provides experienced PSC management in Houston, The Woodlands, Humble, and Baytown via gimed.net. If you've been diagnosed with PSC or have chronic liver or bile duct symptoms, trust our team for ongoing, specialized care.

Diagnosis

Primary Sclerosing Cholangitis (PSC) is a chronic, progressive liver disease involving inflammation and scarring of the bile ducts. It can lead to liver failure or bile duct cancer if left unmanaged. Early diagnosis helps guide surveillance and symptom management.

Primary Sclerosing Cholangitis (PSC)

Confirmed by cholangiography (MRCP or ERCP) showing multifocal bile duct strictures, often with elevated liver enzymes (especially ALP).

Inflammatory Bowel Disease with Abnormal Liver Tests

PSC is frequently associated with ulcerative colitis, and abnormal liver function tests may lead to diagnosis.

Chronic Cholestatic Liver Disease (Unknown Etiology)

When bile duct damage is present without obvious cause, PSC is considered and diagnosed through imaging and biopsy.

Primary Sclerosing Cholangitis (PSC) Management
Technology & Facilities

Digestive & Liver Disease Consultants, P.A. provides advanced care for PSC with a multidisciplinary approach focused on early detection, complication prevention, and long-term liver health.

Magnetic Resonance Cholangiopancreatography (MRCP) Imaging Access

Endoscopic Retrograde Cholangiopancreatography (ERCP) for Bile Duct Evaluation & Treatment

Liver Function and Autoimmune Marker Testing

Surveillance for Cholangiocarcinoma and Liver Transplant Evaluation

Frequently Asked Questions
Primary Sclerosing Cholangitis (PSC) is a chronic liver disease where inflammation and scarring damage the bile ducts, leading to liver damage.
The exact cause is unknown, but PSC is believed to be an autoimmune condition, often associated with inflammatory bowel disease (IBD), particularly ulcerative colitis.
Symptoms may include fatigue, itching, jaundice, abdominal pain, fever, and unexplained weight loss.
PSC is diagnosed through liver function tests, imaging (MRCP or ERCP), and sometimes liver biopsy.
There is currently no cure for PSC. Management focuses on symptom relief, preventing complications, and monitoring disease progression.
Treatments may include medications to relieve itching, antibiotics for infections, endoscopic procedures to open narrowed bile ducts, and liver transplant in advanced cases.
Yes, PSC can eventually lead to cirrhosis and liver failure if not effectively managed.
Yes, patients with PSC and ulcerative colitis have a higher risk of developing colorectal cancer.
Yes, PSC can recur in some patients after liver transplantation, although it is relatively uncommon.
Regular monitoring with liver function tests, imaging, and cancer screening is recommended every 6 to 12 months.
PSC is not directly inherited, but there may be a genetic predisposition in some individuals.
While there's no specific PSC diet, a balanced, low-fat, nutrient-rich diet can support liver health. Patients with fat malabsorption may need vitamin supplements.
Yes, PSC increases the risk of cholangiocarcinoma (bile duct cancer), which requires regular surveillance.
PSC affects both intrahepatic and extrahepatic bile ducts and is commonly associated with IBD, while PBC mainly affects the small intrahepatic bile ducts and is autoimmune in nature.
Yes, vaccinations, especially against hepatitis A and B, are recommended to prevent additional liver complications.

Best Primary Sclerosing Cholangitis (PSC) Management in North Houston, Humble & The Woodlands

The Primary Sclerosing Cholangitis (PSC) Management Services at Digestive & Liver Disease Consultants, P.A. in North Houston, Humble, and The Woodlands offer specialized care for patients with this rare and progressive bile duct disorder. Our experienced hepatology team uses advanced diagnostics, including liver function tests, MRCP imaging, and liver biopsy, to monitor disease progression. We provide individualized treatment plans focused on symptom management, preventing complications, and long-term liver monitoring. Our goal is to maintain liver function and quality of life through proactive and compassionate care.